Basic Information
ID: ALA4416859
Type: Binding
Description: Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysis
Format: BAO_0000219
Organism: Hepatitis B virus
Target: Core antigen(ALA1075091)
Document: ALA4414644
Inhibition of capsid in HBV infected in human HepG.2.2.15 cells assessed as reduction of HBV DNA incubated for 5 days by quantitative PCR analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4416859
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 494.93 | 2.24 | 2.24 |
| 474.51 | 1.98 | 1.98 |
| 508.96 | 2.63 | 2.63 |
| 492.50 | 2.12 | 2.12 |
| 514.91 | 3.25 | 3.25 |
| 528.94 | 3.64 | 3.64 |
| 539.38 | 2.35 | 2.35 |
| 508.96 | 2.63 | 2.63 |
| 510.49 | 2.25 | 2.25 |
| 492.50 | 2.12 | 2.12 |
| 499.52 | 1.85 | 1.85 |
| 474.51 | 1.89 | 1.89 |
| 474.51 | 1.98 | 1.98 |
| 553.41 | 2.74 | 2.74 |
| 498.46 | 2.73 | 2.73 |
| 478.48 | 1.72 | 1.72 |
| 510.49 | 2.25 | 2.25 |
| 498.46 | 2.73 | 2.73 |
| 494.93 | 2.24 | 2.24 |
| 553.41 | 2.74 | 2.74 |
| 488.54 | 2.28 | 2.28 |
| 508.96 | 2.63 | 2.63 |